Natriuretic peptide guided heart failure management. Curr Clin Pharmacol 2009 May;4(2):87-94
Date
05/16/2009Pubmed ID
19442073DOI
10.2174/157488409788184945Scopus ID
2-s2.0-68449088769 (requires institutional sign-in at Scopus site) 10 CitationsAbstract
BNP or NT-proBNP testing has dramatically changed the management of acute heart failure patients by aiding in early recognition, prognostication and treatment. Furthermore, recent studies have shown that natriuretic peptide testing may guide the therapy of the stable chronic heart failure patients in out-patient setting. We will review the understanding of utilizing natriuretic peptide testing to guide heart failure therapy, including present and future directions for this exciting area.
Author List
Mohammed AA, Januzzi JL JrMESH terms used to index this publication - Major topics in bold
Acute DiseaseBiomarkers
Chronic Disease
Clinical Trials as Topic
Heart Failure
Humans
Natriuretic Peptide, Brain
Natriuretic Peptides
Prognosis